The 75 mg dose must be split into three divided doses throughout the day
For therapeutic zinc supplementation at 75 mg elemental zinc daily, the dose should be administered as three divided doses (approximately 25 mg each), taken 30 minutes before meals 1.
Rationale for Divided Dosing
The mechanism of action of zinc in Wilson's disease (the primary therapeutic context for this dose) depends on inducing enterocyte metallothionein in the gastrointestinal tract to block copper absorption. This process requires:
- Continuous zinc presence at the intestinal level to maintain metallothionein induction
- Pre-meal timing (30 minutes before eating) to maximize absorption and prevent interference from food 1
- Multiple daily exposures to sustain the therapeutic effect throughout the day as enterocytes are continuously shed and replaced
Evidence from Guidelines
The EASL Clinical Practice Guidelines for Wilson's Disease explicitly state that 75 mg elemental zinc daily (the pediatric dose for children <50 kg) should be "administered in three divided doses, 30 min before meals" 1. This same three-times-daily regimen applies to the adult dose of 150 mg as well.
Why Once-Daily Dosing Fails
The guidelines acknowledge that "compliance with the three times per day dosage may be problematic" 1, but this does not justify once-daily dosing. The pharmacodynamics require sustained zinc exposure to:
- Continuously induce metallothionein in enterocytes
- Block copper absorption from both dietary sources and gastrointestinal secretions (saliva, gastric juice)
- Maintain therapeutic copper blockade throughout the 24-hour period
Practical Considerations
- Timing is critical: Each dose must be taken 30 minutes before meals to avoid food interference with zinc absorption 1
- Gastric irritation: This is the most common side effect and may vary with different zinc salts (sulfate, acetate, gluconate), though efficacy remains equivalent 1
- Monitoring: Treatment adequacy is assessed by 24-hour urinary copper excretion (<1.6 μmol/24h) and non-ceruloplasmin-bound copper levels 1
The divided dosing regimen is non-negotiable for therapeutic efficacy—once-daily administration would fundamentally undermine the mechanism of action and treatment effectiveness.